Expediting Drug Development in Japan: A PMDA Perspective.
Saved in:
| Title: | Expediting Drug Development in Japan: A PMDA Perspective. |
|---|---|
| Authors: | Kohno Y; Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Ishiguro A; Department of International Programs, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Yasukawa T; Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Yasuda N; Department of International Programs, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Tanaka D; Department of International Programs, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Araki Y; Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Takahashi Y; Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Uyama Y; Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Fujiwara Y; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Dec; Vol. 118 (6), pp. 1262-1264. Date of Electronic Publication: 2025 Aug 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
